UBRELVY
UBRELVY
Approved
DIN Number
02532581
Drug Class
Human
Market Date
Apr 4, 2023
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02532581
AIG Number0164241002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02CD04 UBROGEPANT
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:32.12
Health Canada Classification
ACTIVE INGREDIENTS (1)
UBROGEPANTActive
Strength: 100 MG
Monograph: UBROGEPANT